
Zoxus 500mg/500mg Injection
Marketer
Amista Labs Pvt Ltd
Salt Composition
Cefoperazone (500mg) + Sulbactam (500mg)
Overview Zoxus 500mg/500mg Injection
Combiflox 500mg/500mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus controlling infection spread. Administration must be overseen by a medical professional; adherence to the prescribed schedule is crucial. Complete the entire treatment regimen, even with symptom improvement; premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek immediate medical help for allergic reactions (skin rashes, itching, swelling, or respiratory distress). Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While it typically doesn't impair driving, avoid operating vehicles if experiencing drowsiness or dizziness. Adequate rest, nutrition, and hydration are essential for optimal recovery. Your doctor may order lab tests to monitor treatment response.
Primary Ingredients of Zoxus 500mg/500mg Injection
No text provided to rephrase.
Uses of Zoxus 500mg/500mg Injection
Managing bacterial infections
Major Benefits of Zoxus 500mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Zoxus 500mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Zoxus 500mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Zoxus 500mg/500mg Injection works:
Zoxus 500mg/500mg Injection combines Cefoperazone, a bacteria-fighting antibiotic, with Sulbactam, a beta-lactamase inhibitor. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counters bacterial resistance mechanisms, thereby optimizing Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol alongside Zoxus 500mg/500mg Injection can trigger adverse effects including facial redness, rapid pulse, vomiting, dehydration, pectoral pain, and hypotension (a disulfiram-like response).
PregnancySAFE IF PRESCRIBED
The injectable medication Zoxus 500mg/500mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nonetheless, clinical data from human subjects are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can safely use Zoxus 500mg/500mg Injection. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Zoxus 500mg/500mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Zoxus 500mg/500mg Injection to individuals with renal impairment. Seek medical advice.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Zoxus 500mg/500mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Zoxus 500mg/500mg Injection :
Omitting a scheduled dose of Zoxus 500mg/500mg Injection warrants immediate physician consultation.
Facts to Know About Zoxus 500mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
